keyword
https://read.qxmd.com/read/32749638/management-of-recurrent-clostridioides-infection-a-difficile-problem-in-inflammatory-bowel-disease-patients
#21
JOURNAL ARTICLE
Angela Y Lam, Liat S Gutin, Yume Nguyen, Fernando S Velayos
No abstract text is available yet for this article.
August 4, 2020: Digestive Diseases and Sciences
https://read.qxmd.com/read/32363528/going-viral-management-of-ibd-in-the-era-of-the-covid-19-pandemic
#22
JOURNAL ARTICLE
Liat S Gutin, Angela Y Lam, Fernando S Velayos, Stephanie A Santos
No abstract text is available yet for this article.
May 4, 2020: Digestive Diseases and Sciences
https://read.qxmd.com/read/32253718/correction-to-effectiveness-of-switching-from-reference-product-infliximab-to-infliximab-dyyb-in-patients-with-inflammatory-bowel-disease-in-an-integrated-healthcare-system-in-the-united-states-a-retrospective-propensity-score-matched-non-inferiority-cohort
#23
JOURNAL ARTICLE
Stephanie L Ho, Fang Niu, Suresh Pola, Fernando S Velayos, Xian Ning, Rita L Hui
The article Effectiveness of Switching from Reference Product Infliximab to Infliximab-Dyyb in Patients with Inflammatory Bowel Disease in an Integrated Healthcare System in the United States: A Retrospective, Propensity Score-Matched, Non-Inferiority Cohort Study, written by Stephanie L. Ho, Fang Niu, Suresh Pola, Fernando S. Velayos, Xian Ning and Rita L. Hui, was originally published electronically on 26 February 2020 without open access.
June 2020: BioDrugs: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
https://read.qxmd.com/read/32103457/effectiveness-of-switching-from-reference-product-infliximab-to-infliximab-dyyb-in-patients-with-inflammatory-bowel-disease-in-an-integrated-healthcare-system-in-the-united-states-a-retrospective-propensity-score-matched-non-inferiority-cohort-study
#24
JOURNAL ARTICLE
Stephanie L Ho, Fang Niu, Suresh Pola, Fernando S Velayos, Xian Ning, Rita L Hui
PURPOSE: The aim was to compare outcomes in adult patients with inflammatory bowel disease (IBD) who switched to infliximab-dyyb with those who remained on reference product (RP) infliximab in the United States (US) in a retrospective, propensity score-matched, non-inferiority cohort trial. METHODS: This study was a retrospective, non-inferiority study conducted within a US integrated healthcare system and included adult patients with a confirmed diagnosis of Crohn's disease or ulcerative colitis...
June 2020: BioDrugs: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
https://read.qxmd.com/read/31705343/elevating-the-technique-resecting-complex-dysplastic-lesions-of-the-colon-in-patients-with-inflammatory-bowel-disease
#25
JOURNAL ARTICLE
Eshandeep S Boparai, Fernando S Velayos, Abhik Roy, Carolyn Li, Ahmed S Alkoraishi, Craig A Munroe
No abstract text is available yet for this article.
November 9, 2019: Digestive Diseases and Sciences
https://read.qxmd.com/read/31529414/it-s-what-s-up-front-that-counts-part-one-endoscopic-diagnosis-and-therapy-of-esophageal-crohn-s-disease
#26
JOURNAL ARTICLE
Latifat Alli-Akintade, Jennifer Hewitt, Asraa Namiq, Maneesh Singh, Yume Nguyen, Sara Keihanian, Jennifer T Chang, Sundip Karsan, Samuel Tesfay, Fernando S Velayos
No abstract text is available yet for this article.
September 16, 2019: Digestive Diseases and Sciences
https://read.qxmd.com/read/30980712/improving-the-quality-of-inpatient-ulcerative-colitis-management-promoting-evidence-based-practice-and-reducing-care-variation-with-an-inpatient-protocol
#27
JOURNAL ARTICLE
Sara M Lewin, Ryan A McConnell, Roshan Patel, Suzanne R Sharpton, Fernando Velayos, Uma Mahadevan
BACKGROUND: Hospitalization for ulcerative colitis is a high-risk period associated with increased risk of Clostridium difficile infection, thromboembolism, and opiate use. The study aim was to develop and implement a quality-improvement intervention for inpatient ulcerative colitis management that standardizes gastroenterology consultant recommendations and improves delivery of evidence-based care. METHODS: All adult patients hospitalized for ulcerative colitis between July 1, 2014, and December 31, 2017, who received intravenous corticosteroids were included...
October 18, 2019: Inflammatory Bowel Diseases
https://read.qxmd.com/read/30928454/appropriate-therapeutic-drug-monitoring-of-biologic-agents-for-patients-with-inflammatory-bowel-diseases
#28
JOURNAL ARTICLE
Konstantinos Papamichael, Adam S Cheifetz, Gil Y Melmed, Peter M Irving, Niels Vande Casteele, Patricia L Kozuch, Laura E Raffals, Leonard Baidoo, Brian Bressler, Shane M Devlin, Jennifer Jones, Gilaad G Kaplan, Miles P Sparrow, Fernando S Velayos, Thomas Ullman, Corey A Siegel
BACKGROUND & AIMS: Therapeutic drug monitoring (TDM) is widely available for biologic therapies in patients with inflammatory bowel disease (IBD). We reviewed current data and provided expert opinion regarding the clinical utility of TDM for biologic therapies in IBD. METHODS: We used a modified Delphi method to establish consensus. A comprehensive literature review was performed regarding the use of TDM of biologic therapy in IBD and presented to international IBD specialists...
August 2019: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/30565011/introduction-to-the-ibd-case-conference-series
#29
EDITORIAL
Fernando Velayos
No abstract text is available yet for this article.
December 18, 2018: Digestive Diseases and Sciences
https://read.qxmd.com/read/30523483/how-dye-may-prevent-dying-from-cancer-perceiving-imperceptible-dysplasia-in-inflammatory-bowel-disease
#30
JOURNAL ARTICLE
Sara M Lewin, Kwun Wah Wen, Fernando S Velayos, Uma Mahadevan, Kendall R Beck
No abstract text is available yet for this article.
December 7, 2018: Digestive Diseases and Sciences
https://read.qxmd.com/read/29505910/appropriateness-of-combination-therapy-for-patients-with-inflammatory-bowel-diseases-one-size-still-does-not-fit-all
#31
JOURNAL ARTICLE
Gil Y Melmed, Gilaad G Kaplan, Miles P Sparrow, Fernando S Velayos, Leonard Baidoo, Brian Bressler, Adam S Cheifetz, Shane M Devlin, Peter M Irving, Jennifer Jones, Patricia L Kozuch, Laura E Raffals, Corey A Siegel
No abstract text is available yet for this article.
March 2, 2018: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/28838412/intestinal-and-nonintestinal-cancer-risks-for-patients-with-crohn-s-disease
#32
REVIEW
Sushil K Garg, Fernando S Velayos, John B Kisiel
Crohn's disease (CD) is a chronic inflammatory disease that confers a higher risk of cancer than in the general population. New, large, population-based studies in the past decade show that patients with CD are at higher risk of colorectal, small bowel, melanoma, and cervical cancer. Patients who use thiopurines are at additional risk of development of lymphoma and nonmelanoma skin cancer. Preventive surveillance for cancers of the colorectum, skin, and uterine cervix is advised.
September 2017: Gastroenterology Clinics of North America
https://read.qxmd.com/read/27765687/changing-paradigms-in-detection-of-dysplasia-and-management-of-patients-with-inflammatory-bowel-disease-is-colectomy-still-necessary
#33
REVIEW
Fernando Velayos, Priya Kathpalia, Emily Finlayson
This review chronicles the evolution of dysplasia detection and management in inflammatory bowel disease since 1925, the year the first case report of colitis-related colorectal cancer was published. We conclude that colorectal cancer prevention and dysplasia management for patients with inflammatory bowel disease has changed since this first case report, from somewhat hopeless to hopeful.
February 2017: Gastroenterology
https://read.qxmd.com/read/27189916/appropriateness-of-testing-for-anti-tumor-necrosis-factor-agent-and-antibody-concentrations-and-interpretation-of%C3%A2-results
#34
JOURNAL ARTICLE
Gil Y Melmed, Peter M Irving, Jennifer Jones, Gilaad G Kaplan, Patricia L Kozuch, Fernando S Velayos, Leonard Baidoo, Miles P Sparrow, Brian Bressler, Adam S Cheifetz, Shane M Devlin, Laura E Raffals, Niels Vande Casteele, Diane R Mould, Jean-Fred Colombel, Marla Dubinsky, William J Sandborn, Corey A Siegel
BACKGROUND & AIMS: The availability of tests for blood concentrations of anti-tumor necrosis factor (TNF) agents and antibodies against these drugs could improve dose selection for patients with inflammatory bowel disease (IBD). However, there is little consensus on when to test and how to interpret test results. We used the RAND/UCLA Appropriateness Method to determine when these tests are appropriate and how to clinically interpret their results. METHODS: We conducted a systematic literature search in November 2013 to identify observational or experimental studies of the measurement of anti-TNF drug and antibody concentrations in patients with IBD and interpretation of their results...
September 2016: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/27057680/recommendations-for-quality-colonoscopy-reporting-for-patients-with-inflammatory-bowel-disease-results-from-a-rand-appropriateness-panel
#35
JOURNAL ARTICLE
Shane M Devlin, Gil Y Melmed, Peter M Irving, David T Rubin, Asher Kornbluth, Patricia L Kozuch, Laura E Raffals, Fernando S Velayos, Miles P Sparrow, Leonard Baidoo, Brian Bressler, Adam S Cheifetz, Jennifer Jones, Gilaad G Kaplan, Corey A Siegel
BACKGROUND: Consensus on what constitutes a quality colonoscopy report for patients with inflammatory bowel disease (IBD) is lacking. We developed a template for quality colonoscopy reporting that can be used broadly by endoscopists. METHODS: After a literature review of topics relevant to colonoscopy reporting, members of the Building Research in Inflammatory Bowel Disease Globally (BRIDGe) group and 2 external experts proposed candidate reporting elements. The RAND/University of California, Los Angeles appropriateness method was applied to rate the importance and feasibility of elements for inclusion in colonoscopy reports for patients with IBD...
June 2016: Inflammatory Bowel Diseases
https://read.qxmd.com/read/26364967/a-roadmap-to-the-implementation-of-chromoendoscopy-in-inflammatory-bowel-disease-colonoscopy-surveillance-practice
#36
JOURNAL ARTICLE
Silvia Sanduleanu, Tonya Kaltenbach, Alan Barkun, Robert P McCabe, Fernando Velayos, Michael F Picco, Loren Laine, Roy Soetikno, Kenneth R McQuaid
No abstract text is available yet for this article.
January 2016: Gastrointestinal Endoscopy
https://read.qxmd.com/read/26142167/effects-of-concomitant-immunomodulator-therapy-on-efficacy-and-safety-of-anti-tumor-necrosis-factor-therapy-for-crohn-s-disease-a-meta-analysis-of-placebo-controlled-trials
#37
REVIEW
Jennifer L Jones, Gilaad G Kaplan, Laurent Peyrin-Biroulet, Leonard Baidoo, Shane Devlin, Gil Y Melmed, Divine Tanyingoh, Laura Raffals, Peter Irving, Patricia Kozuch, Miles Sparrow, Fernando Velayos, Brian Bressler, Adam Cheifetz, Jean-Frederic Colombel, Corey A Siegel
BACKGROUND & AIMS: There is debate over whether patients with Crohn's disease who start anti-tumor necrosis factor (TNF) therapy after failed immunomodulator therapy should continue to receive concomitant immunomodulators. We conducted a meta-analysis of subgroups from randomized controlled trials (RCTs) of anti-TNF agents to compare the efficacy and safety of concomitant immunomodulator therapy vs anti-TNF monotherapy. METHODS: We performed a systematic review of literature published from 1980 through 2008 and identified 11 RCTs of anti-TNF agents in patients with luminal or fistulizing Crohn's disease...
December 2015: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/25721001/colorectal-cancer-screening-and-surveillance-in-the-elderly-updates-and-controversies
#38
REVIEW
Lukejohn W Day, Fernando Velayos
Colorectal cancer is common worldwide, and the elderly are disproportionately affected. Increasing age is a risk factor for the development of precancerous adenomas and colorectal cancer, thus raising the issue of screening and surveillance in older patients. Elderly patients are a diverse and heteroge-neous group, and special considerations such as comorbid medical conditions, functional status and cognitive ability play a role in deciding on the utility of screening and sur-veillance. Colorectal cancer screening can be beneficial to patients, but at certain ages and under some circumstances the harm of screening outweighs the benefits...
March 2015: Gut and Liver
https://read.qxmd.com/read/25325227/braden-scale-and-norton-scale-modified-by-insalud-in-an-acute-care-hospital-validity-and-cutoff-point
#39
JOURNAL ARTICLE
Jose M González-Ruiz, Tomas Sebastián-Viana, Marta E Losa-Iglesias, Isabel Lema-Lorenzo, Fernando J Núñez Crespo, Gema Martín-Merino, Maria R García-Martín, Eva Velayos-Rodríguez, Carmen G Nogueiras-Quintas
OBJECTIVE: The objective of this article was to determine the most suitable cutoff point (CP) for the Braden Scale and Norton Modified Scale by INSALUD Scale (Norton-MI) in an acute care hospital. DESIGN: The authors have designed a prospective, descriptive study of patients from their hospital. From December 2008 to March 2009, a nurse collected and recorded adult patient data daily, including the appearance of pressure ulcers. PATIENTS: Adult patients in medical and surgical wards...
November 2014: Advances in Skin & Wound Care
https://read.qxmd.com/read/24975529/quality-bowel-preparation-for-surveillance-colonoscopy-in-patients-with-inflammatory-bowel-disease-is-a-must
#40
REVIEW
Andrew Nett, Fernando Velayos, Kenneth McQuaid
Colonoscopy is routinely performed in patients with inflammatory bowel disease (IBD) for surveillance of dysplasia. Thorough bowel preparation is necessary to facilitate lesion detection. Patients with IBD do not have poorer bowel preparation outcomes but may have decreased preparation tolerance affecting adherence to surveillance protocols. A low-fiber prepreparation diet may improve preparation tolerance without affecting preparation quality. The standard preparation regimen should consist of split-dose administration of a polyethylene glycol-based purgative...
July 2014: Gastrointestinal Endoscopy Clinics of North America
keyword
keyword
111508
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.